Turning interest into signed deals

Why do good deals stall without anyone saying no?

Because the buyer is not choosing between you and a competitor. They are choosing between acting and not acting, and not acting is the safer choice for everyone in the room. A deal that goes quiet after a strong discovery call has usually not been lost to a rival — it has been lost to indecision, and indecision does not send a rejection email.

This is the best-documented failure mode in B2B selling and one of the least often diagnosed, because it does not appear in a CRM as a loss. It appears as a date that keeps moving.

What the research shows

The JOLT Effect research, which analysed 2.5 million recorded sales conversations, found that between 40% and 60% of B2B deals are lost to customer indecision rather than to a competitor, and that 87% of customers demonstrated moderate or high levels of indecision. Losing to "no decision" is not the tail of the distribution; it is most of it.

Gartner's sales survey, published on 7 May 2025, found that 74% of B2B buying teams demonstrate "unhealthy conflict" during the decision process. Put those two findings together and the shape of the problem is clear: the obstacle is usually inside the buying group, in a conversation you are not in, between people you may never meet.

How do you find out why deals are really lost?

You ask the buyers, and you are not the person who should ask them. Win/loss analysis is a short set of structured interviews with people who recently chose you and people who recently did not, run by someone outside the company. The reason it needs an outsider is mechanical rather than diplomatic: a buyer will not tell the salesperson who just lost the deal what actually decided it. What the rep hears is that it was a close decision. What a neutral interviewer hears is the criterion nobody surfaced, the internal objection nobody answered, or the fact that the budget was never approved.

Five to eight win-loss interviews will surface real signal, and at that size the work is honestly described as a diagnosis rather than a study — below roughly fifteen you are reading anecdotes rather than statistically meaningful patterns. How win/loss analysis works covers who to interview, when to do it, and how the conversations become data rather than impressions.

This is the input the rest of the work depends on. Diagnosing deal stalls from CRM notes alone means running a deal review on the account team's account of events, which is the one version of the story guaranteed to be missing the reason.

Why the standard responses make it worse

The instinctive reaction to a stalled deal is more pressure and more value: another follow-up, another case study, another discount. All three treat the problem as insufficient desire.

But a buyer stalling from indecision is not unconvinced that the product is good. They are worried about being wrong — about the implementation, about a criterion they have not checked, about what happens to them personally if it does not work. Adding more reasons to want it does not touch any of that, and a discount actively raises the question of why the price moved.

What the work involves

1. Diagnose which stall this is. Indecision, a genuine competing priority, an unfunded initiative and a champion who has lost internal standing all look identical from the outside and need opposite responses.
2. Map the buying group. Who signs, who blocks, who has to live with the outcome, and who has not been in a single conversation yet. Single-threaded deals are the ones that go quiet.
3. Find the unasked question. The specific thing the buyer is afraid of that has never been said out loud, usually because saying it feels like an admission.
4. Reduce the downside, not the price. Scope the first step so that being wrong is survivable — which is what a hesitant buyer is actually buying.
5. Arm the champion. Your advocate is arguing your case in meetings you are not in, against colleagues in conflict. Give them something built for that room.
6. Rebuild the qualification. So the next deal that looks like this one gets diagnosed at the start rather than at the point it stops responding. In practice that means a pipeline review that asks one extra question of every open deal: what is this buyer afraid of, and has anyone said it out loud?

What this is, and what it is not

This is the process and judgment layer of revenue operations: pipeline definitions that mean the same thing to everyone who uses them, qualification criteria that catch a no-decision risk at the start rather than at the point a deal stops responding, and forecast discipline that survives a bad quarter. Forecast accuracy improves as a by-product, because a pipeline with its indecision risk named is a pipeline you can actually forecast.

If what you need is someone to rebuild your Salesforce or HubSpot instance — lifecycle stages, routing rules, integrations, reporting architecture — that is a different job and a different person, and I will tell you so rather than take it on. The sales process work here changes what gets asked and recorded, not what the system is built on.

Where this sits

This is the far end of the same problem the rest of this practice works on. Visibility decides whether you are in the shortlist. Market entry decides whether the segment was worth entering. This decides whether the resulting conversations become signed business — and it comes from carrying a quota in industrial B2B rather than from a marketing playbook.